Shenzhen Antmed Co., Ltd. is a leading provider of medical devices, specializing in CT, MRI, and DSA contrast media injectors, consumables, and pressure IV catheters. The company has achieved domestic market leadership in high-pressure syringe and Disposable Pressure Transducers industry sectors. Operating since 2000, Antmed's products are distributed in over 100 countries and regions across the Americas, Europe, Asia, Oceania, and Africa.
Antmed's commitment to quality is evident through its adherence to stringent quality management systems and certifications, including EN ISO 13485, 21 CFR 820, MDSAP, ISO 11135, and registrations from regulatory bodies such as USA FDA(510K), Canada MDL, Brazil ANVISA, Australia TGA, Russia RNZ, South Korea KFDA, and others. The company has also been recognized as an annual quality credit class-A medical device manufacturer in Guangdong province for six consecutive years.
As a National Hi-Tech Enterprise, Antmed demonstrates strong capabilities in product development, mold manufacturing, large-scale production, and efficient domestic and international sales networks. The short-term goal of the company is to establish leadership in the global contrast imaging industry, while its long-term vision is to become a globally respected entity in the medical device industry. Antmed is positioned to make substantial contributions to China's medical reforms and the globalization of the country's mid-to-high-end manufacturing industry.
Overall, Antmed's comprehensive offering, global reach, and commitment to quality position it as an attractive prospect for investors seeking opportunities in the IT, Manufacturing, and Medical Devices industries.
There is no investment information
No recent news or press coverage available for Shenzhen Antmed Co., Ltd..